Hong Kong superbug surge prompts fears over ‘big gun’ antibiotics
Statistics reveal a seven-fold rise in one particular type of superbug case, more than 30 per cent of which were imported
The health consequences of overreliance on antibiotics are in the spotlight again after a seven-fold increase in drug-resistant superbug cases in public hospitals.
The number for one particular type of drug-resistant superbug rose from 19 cases in 2011 to 134 last year following the increasing use of “big gun” antibiotics for patients who were critically ill or resistant to regular drugs.
The Hospital Authority is stepping up efforts to curb in particular cases of carbapenemase-producing enterobacteriaceae (CPE), which is a kind of gut bacteria.
Carbapenemase are enzymes produced by bacteria that can break down “big gun” antibiotics called carbapenems.
Starting in July, patients will be screened for superbugs if they have spent time in hospitals outside Hong Kong within the past year, instead of the current six months.
Among the 134 cases recorded among public hospital patients last year, 102 were of a more severe type which had higher transmission rates. More than 30 per cent were imported, with half linked to mainland hospital stays within the previous six months.